Who
Frederick G. Vogt
Interim CEO & General Counsel
Company insider
Files Form 4 as: Interim CEO & General Counsel, Iovance Biotherapeutics.
In numbers
- Trades disclosed
- 115
- Buys
- 3
- Sells
- 0
- Bought
- $55K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Dec 2017
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —15,626 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $58K6,638 at $8.70 | filing |
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,626 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,626 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —15,626 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $58K6,638 at $8.70 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —41,669 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $147K17,702 at $8.28 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —41,669 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —41,669 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —41,669 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $147K17,702 at $8.28 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —15,625 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $28K6,638 at $4.23 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,625 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,625 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —15,625 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $28K6,638 at $4.23 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —41,668 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $70K17,701 at $3.96 | filing |
News
Undercovered Stocks: Hess Midstream, Iovance Biotherapeutics, Netlist, And MoreIOVA · seekingalpha.com · 19 Oct 2026Comparing MannKind (NASDAQ:MNKD) & Iovance Biotherapeutics (NASDAQ:IOVA)IOVA · tickerreport.com · 15 Oct 2026Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Raised to $11.00IOVA · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name Frederick G. Vogt; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.